Evidence map›Paper›PMID 33031047›Full record

ArticleJournal of medical Internet research2020

Telemedicine Usage Among Urologists During the COVID-19 Pandemic: Cross-Sectional Study.

Justin M Dubin, W Austin Wyant, Navin C Balaji, William Lk Ong, Reda H Kettache, Malik Haffaf, Skander Zouari, Diego Santillan, Ana Maria Autrán Gómez, Hossein Sadeghi-Nejad and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Testosterone replacement therapy in the era of telemedicine.International journal of impotence research · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 8 countries.

Justin M DubinDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL, United States.ORCID 0000-0001-7401-6206
W Austin WyantDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL, United States.ORCID 0000-0002-2277-1549
Navin C BalajiDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL, United States.ORCID 0000-0002-9945-6651
William Lk OngDepartment of Urology, Penang General Hospital, Penang, Malaysia.ORCID 0000-0002-3048-1170
Reda H KettacheDepartment of Urology, Bachir Bennacer - Biskra Hospital, Biskra, Algeria.ORCID 0000-0001-9062-9782
Malik HaffafDepartment of Urology, EHU 1er Novembre, Oran, Algeria.ORCID 0000-0001-8408-3744
Skander ZouariUrology Department, Charles Nicolle Hospital, Tunis, Tunisia.ORCID 0000-0003-4644-489X
Diego SantillanDepartment of Urology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.ORCID 0000-0003-0532-1738
Ana Maria Autrán GómezDepartment of Urology, Hospital Universitario Fundación Jiménez Diaz, Madrid, Spain.ORCID 0000-0002-4961-5669
Hossein Sadeghi-NejadDepartment of Urology, Rutgers New Jersey Medical School, Newark, NJ, United States.ORCID 0000-0002-4032-8110
Stacy LoebDepartment of Urology and Population Health, New York University and Manhattan Veterans Affairs Medical Center, New York City, NY, United States.ORCID 0000-0003-3933-9207
James F BorinDepartment of Urology, New York University, New York City, NY, United States.ORCID 0000-0002-1217-1566
Juan Gomez RivasDepartment of Urology, La Paz University Hospital, Madrid, Spain.ORCID 0000-0002-0556-3035
Jeremy GrummetDepartment of Surgery, Central Clinical School, Monash University, Melbourne, Australia.ORCID 0000-0003-4382-8169
Ranjith RamasamyDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL, United States.ORCID 0000-0003-1387-7904
Jeremy Y C TeohSH Ho Urology Centre, Prince of Wales Hospital, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.ORCID 0000-0002-9361-2342
University of Miami · USNew York University · USChinese University of Hong Kong · HKHôpital Charles-Nicolle · TNHospital Italiano de Buenos Aires · ARHospital Universitario Fundación Jiménez Díaz · ESHospital Universitario La Paz · ESMonash University · AURutgers, The State University of New Jersey · USUniversity Hospital of Oran · DZUniversity of Biskra · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrior to the COVID-19 pandemic, urology was one of the specialties with the lowest rates of telemedicine and videoconferencing use. Common barriers to the implementation of telemedicine included a lack of technological literacy, concerns with reimbursement, and resistance to changes in the workplace. In response to the COVID-19 pandemic declared in March 2020, the delivery of urological services globally has quickly shifted to telemedicine to account for the mass clinical, procedural, and operative cancellations, inadequate personal protective equipment, and shortage of personnel.

objectiveThe aim of this study was to investigate current telemedicine usage by urologists, urologists' perceptions on the necessity of in-person clinic appointments, the usability of telemedicine, and the current barriers to its implementation.

methodsWe conducted a global, cross-sectional, web-based survey to investigate the use of telemedicine before and after the COVID-19 pandemic. Urologists' perceived usability of telemedicine was assessed using a modified Delphi approach to create questions based on a modified version of the validated Telehealth Usability Questionnaire (TUQ). For the purposes of this study, telemedicine was defined as video calls only.

resultsA total of 620 urologists from 58 different countries and 6 continents participated in the survey. Prior to COVID-19, 15.8% (n=98) of urologists surveyed were using telemedicine in their clinical practices; during the pandemic, that proportion increased to 46.1% (n=283). Of the urologists without telemedicine experience, interest in telemedicine usage increased from 43.7% (n=139) to 80.8% (n=257) during the COVID-19 pandemic. Among urologists that used telemedicine during the pandemic, 80.9% (n=244) were interested in continuing to use it in their practice. The three most commonly used platforms were Zoom, Doxy.me, and Epic, and the top three barriers to implementing telemedicine were patients' lack of technological comprehension, patients' lack of access to the required technology, and reimbursement concerns.

conclusionsThis is the first study to quantify the use, usability, and pervading interest in telemedicine among urologists during the COVID-19 pandemic. In the face of this pandemic, urologists' usage of telemedicine nearly tripled, demonstrating their ability to adopt and adapt telemedicine into their practices, but barriers involving the technology itself are still preventing many from utilizing it despite increasing interest.

Indexed as

AdultCOVID-19Cross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesTelemedicineUrologistsbarriercoronavirusCOVID-19cross-sectionalimplementationperceptiontechnologytelehealthtelemedicineurologyusability

Identifiers

PMID33031047
PMCPMC7647472
OpenAlexW3088785733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.